1. Advances in the study of marketed antibody-drug Conjugates (ADCs) for the treatment of breast cancer
   Yan Liang et al, 2024, Frontiers in Pharmacology CrossRef
2. ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer
   Marco La Ferla et al, 2019, Frontiers in Oncology CrossRef
3. Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
   Inna P. Ganshina et al, 2021, Journal of Modern Oncology CrossRef
4. Trop2 Expression in Extramammary Paget’s Disease and Normal Skin
   Takamichi Ito et al, 2021, International Journal of Molecular Sciences CrossRef
5. Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
   Sara Bravaccini et al, 2021, Journal of Personalized Medicine CrossRef
6. TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial–Mesenchymal Transition and Invasiveness
   Jiří Švec et al, 2022, Cancers CrossRef
7. TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer
   Xiaoyue Liu et al, 2022, OncoTargets and Therapy CrossRef
8. Cancer-Associated Membrane Protein as Targeted Therapy for Bladder Cancer
   Adlina Roslan et al, 2022, Pharmaceutics CrossRef
9. A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid Tumors
   Giuliana Pavone et al, 2021, Molecules CrossRef
10. Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything
    Serena Capici et al, 2022, Cancers CrossRef
11. Narrowing the focus: Therapeutic cell surface targets for refractory triple-negative breast cancer
    Narges K Tafreshi et al, 2020, World Journal of Clinical Oncology CrossRef
12. Toxicarioside O Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition by Downregulation of Trop2 in Lung Cancer Cells
    Wu-Ping Zheng et al, 2021, Frontiers in Oncology CrossRef
13. Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer
    Neelima Vidula et al, 2022, Breast Cancer Research and Treatment CrossRef
14. Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments
    Shota Omori et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
15. Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
    Liqin Yao et al, 2023, Frontiers in Oncology CrossRef
16. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma
    Ramona Erber et al, 2021, International Journal of Molecular Sciences CrossRef
17. TROP2 Expression in Sebaceous and Sweat Gland Carcinoma
    Takamichi Ito et al, 2022, Journal of Clinical Medicine CrossRef
18. Trop2: Jack of All Trades, Master of None
    Sára Lenárt et al, 2020, Cancers CrossRef
19. Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab
    María Gion et al, 2024, Breast Cancer Research and Treatment CrossRef